Detalhe da pesquisa
1.
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.
Vaccine
; 31(48): 5772-7, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23968769
2.
Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
Vaccine
; 26(7): 882-90, 2008 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-18207289
3.
Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
Vaccine
; 24(40-41): 6392-404, 2006 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-16831498
4.
West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.
Proc Natl Acad Sci U S A
; 99(5): 3036-41, 2002 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-11880643
5.
Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
Virology
; 314(1): 190-5, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14517072